Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR2 | P30518 | 4/20 | 0.35 |
| ▸ | AVPR1A | P37288 | 4/20 | 0.35 |
| ▸ | AVPR1B | P47901 | 4/20 | 0.35 |
| ▸ | MAP3K7 | O43318 | 4/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 2/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7966770 | 0.91 | IRAK4 (0.34) | IRAK4 | |
| SCHEMBL7969774 | 0.89 | MAP3K7 (0.38) | AVPR2AVPR1AMAP3K7JAK2LCK | |
| SCHEMBL7970647 | 0.86 | MAP3K7 (0.38) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| Hydrochloric Acid SCHEMBL7954456 | 0.86 | MAP3K7 (0.38) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| SCHEMBL7966116 | 0.86 | MAP3K7 (0.38) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| SCHEMBL7966800 | 0.86 | AVPR2 (0.38) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| SCHEMBL7962075 | 0.86 | MAP3K7 (0.39) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| Hydrochloric Acid SCHEMBL7964669 | 0.85 | MAP3K7 (0.38) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| Hydrochloric Acid SCHEMBL7483860 | 0.85 | AVPR2 (0.37) | AVPR2AVPR1AAVPR1BMAP3K7IRAK4 | |
| SCHEMBL7955162 | 0.85 | AVPR2 (0.35) | AVPR2AVPR1AAVPR1BMAP3K7ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316482-B1 | FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |